Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

eyes absent Inhibitors

Eyes absent (EYA) inhibitors are a class of chemical compounds that target and inhibit the activity of the Eyes Absent (EYA) family of proteins, which are part of a complex regulatory system involved in transcriptional coactivation and phosphatase activity. The EYA proteins function as dual-action enzymes, with a primary role in dephosphorylating both serine/threonine and tyrosine residues on proteins. These phosphatases participate in numerous cellular processes, including DNA repair, cell differentiation, and the regulation of developmental pathways. EYA proteins work in tandem with other protein families, such as Six and Dach, forming an intricate signaling network that governs gene expression and cellular responses. Inhibition of EYA proteins can have a substantial impact on these pathways, making them crucial targets for studying cellular regulation and enzyme function.

Structurally, EYA proteins contain a conserved C-terminal phosphatase domain responsible for their enzymatic activity, while the N-terminal region interacts with other transcription factors, facilitating gene regulatory roles. EYA inhibitors typically function by binding to the active site of the phosphatase domain, thereby blocking its catalytic activity. This inhibition can alter the phosphorylation status of key signaling proteins, which in turn affects processes such as cell cycle progression and response to DNA damage. EYA inhibitors are useful in dissecting the biochemical pathways controlled by EYA proteins and can serve as important tools in molecular biology for studying the roles of phosphatases in cellular function. These compounds provide insights into enzyme mechanisms, protein-protein interactions, and their broader roles in regulatory networks, offering a deeper understanding of the biochemistry behind phosphatase-mediated signal transduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that leads to reduced Akt activation. In this context, eyes absent protein often forms a complex with Akt, which affects its phosphorylation and enzymatic activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, leading to reduced protein synthesis. This action depletes the pool of eyes absent protein available for complex formation with other proteins like Six1.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor that can prevent phosphorylation of eyes absent protein, altering its function in downstream cellular pathways like cell cycle control.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that specifically blocks MEK1 and MEK2, thus affecting ERK phosphorylation and the subsequent influence on eyes absent through SPRY4.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor that affects downstream components like MAPKAPK-2, which in turn regulates eyes absent protein by altering its ability to bind to E2F1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that affects AP-1 activation, thereby reducing the transcriptional activation of genes that require eyes absent for chromatin remodeling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor similar to LY294002, but irreversible. Affects Akt activation and subsequent eyes absent protein phosphorylation and enzymatic activity.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$102.00
$138.00
14
(1)

Akt inhibitor that directly inhibits Akt phosphorylation. By inhibiting Akt, eyes absent protein’s activity and complex formation capacities are impacted.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

NF-κB inhibitor that prevents IκBα phosphorylation. This affects the transcriptional activity of eyes absent by preventing its co-activation with NF-κB.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

c-Raf inhibitor that blocks MAPK pathway activation, impacting eyes absent through altered ERK and SPRY4 interactions.